Explore our primary array of clinical-grade physical therapy equipment, smart monitoring devices, and mobility assist systems optimized for international healthcare compliance.
Ningbo FoysMed Solutions Co., Ltd. represents the apex of Chinese medical device manufacturing, bringing engineering rigor, biomedical compliance, and scalable OEM production to the international healthcare sector.
Ningbo FoysMed Solutions Co., Ltd. is a professional medical equipment manufacturer specializing in rehabilitation and mobility solutions, as well as a reliable OEM supplier for global healthcare markets. The company is committed to delivering high-quality, safe, and efficient medical products that support hospitals, clinics, rehabilitation centers, and home care environments.
FoysMed offers a comprehensive range of products, including electric wheelchairs, mobility aids, rehabilitation consumables, wound care products, surgical instruments, and general medical devices. Each product is designed and manufactured in compliance with strict international quality standards, ensuring reliability, durability, and user comfort in a wide variety of medical applications.
With advanced production facilities, precision manufacturing processes, and rigorous quality control systems, Ningbo FoysMed Solutions Co., Ltd. ensures consistent product performance and stable supply capabilities. The company also provides flexible OEM and ODM services, allowing clients to customize product specifications, materials, packaging, and branding to meet specific market demands.
Driven by innovation, quality, and customer satisfaction, FoysMed continues to expand its global presence. The company is dedicated to supporting healthcare providers with dependable medical equipment solutions that improve patient care, enhance rehabilitation outcomes, and contribute to a better quality of life worldwide.
Integrating photobiomodulation, micro-electronics, biomechanical joint kinetics, and environmental micro-sterilization for clinical excellence.
Deep-tissue laser therapy engineered to deliver controlled energy density to sub-dermal target tissues, stimulating mitochondrial ATP synthesis, accelerating microvascular cellular repair, and managing chronic pain conditions through precise thermal modulation.
Combining precision-machined aluminum alloy hinges with soft-tissue compression textiles and micro-current EMS (Electrical Muscle Stimulation) drivers to offer dynamic gait correction, joint unloading, and neuro-muscular retraining during post-operative rehab.
Multi-channel sleep diagnostics monitoring continuous EEG, ECG, SpO2, and respiratory airflow parameters in real-time, feeding clinical-grade data directly to cloud systems for post-acute neurological and cardiopulmonary assessment.
| Technology Matrix | Primary Medical Function | Clinical & Operational Impact | Compliance Benchmark |
|---|---|---|---|
| High-Intensity 980nm Photobiomodulation | Sub-cutaneous tissue regeneration and musculoskeletal pain inhibition | Accelerates muscular recovery rate by up to 40% in post-acute clinical trials | IEC 60601-2-22 / CE Class IIb |
| Intelligent EMS-Integrated Knee Orthotics | Joint stabilization combined with passive dynamic quadriceps activation | Prevents disuse muscle atrophy following major ACL reconstructive surgery | ISO 10993 Biocompatibility |
| Micro-Scale Microwave Disinfection Unit | In-situ sterilization of hazardous bio-medical waste in laboratory settings | Achieves Log 6 reduction in bacterial endospores without toxic chemical discharge | EPA & EU Waste Directive 2008/98/EC |
| DEHP-Free Polymer Infusion Systems | Safe fluid delivery without phthalate leaching into bloodstream | Zero patient risk of plasticizer exposure during extended intravenous therapy | EU MDR 2017/745 / REACH compliant |
Analyzing demographic shifts, healthcare expenditure trends, and the expanding necessity for cost-effective therapeutic aid supply chains across key geographic regions.
The global demand for advanced therapeutic aids and rehabilitation equipment is undergoing an unprecedented expansion, driven predominantly by a rapid global aging demographic, an increasing prevalence of chronic neurological and musculoskeletal conditions, and the post-pandemic paradigm shift toward home-based and decentralised rehabilitation models. According to recent healthcare economic evaluations, the global physical therapy and rehabilitation equipment market is projected to reach over USD 28 Billion by 2030, exhibiting a compounding annual growth rate (CAGR) exceeding 7.2%.
In high-income healthcare economies across North America and Western Europe, reimbursement frameworks such as Medicare and national health service schemes are placing greater emphasis on reducing hospital length-of-stay (LOS). This has elevated the role of home-use therapeutic devices, high-durability mobility frames, continuous patient monitors, and specialized pressure-relief orthotics. Concurrently, emerging economies across Asia-Pacific, Latin America, and the Middle East are executing massive infrastructure upgrades in public health networks, seeking high-reliability medical equipment suppliers who can offer uncompromising product quality combined with aggressive production scalability and flexible OEM/ODM contract terms.
Why Ningbo FoysMed Solutions Co., Ltd. serves as the premier strategic partner for global healthcare distributors, hospital brands, and medical device OEMs.
Situated in Ningbo, one of China's most advanced precision manufacturing and deep-water maritime logistics corridors, FoysMed leverages instant access to raw medical-grade polymers, micro-motor assemblies, structural aluminum tubing, and specialized packaging within a 50-kilometer radius.
Our facilities unite injection molding, CNC precision milling, robotic welding, cleanroom automated assembly, and automated EO (Ethylene Oxide) or Gamma sterilization pathways under a single unified Quality Management System, eliminating third-party delay risks.
Operating under strict ISO 13485 standards, our quality control protocols involve 100% incoming raw material testing, in-process automated vision checking, micro-structural integrity stress testing, and final outgoing sterility assay validations.
Deploying FoysMed therapeutic equipment across diverse institutional settings, from specialized trauma ICUs to home community care networks.
In tertiary care hospitals and post-surgical trauma rehabilitation centers, high-dose photobiomodulation units (980nm therapy laser) and automated limb trainers are integrated directly into early-mobilization protocols. This reduces joint stiffness, attenuates localized post-operative edema, and shortens patient recovery timelines.
Long-term care institutions demand robust, ergonomic, low-maintenance mobility aids and continuous hygiene water filtration systems. FoysMed multi-leg walking frames, customized wheel chairs, and large-scale water treatment equipment ensure senior safety, prevent falls, and maintain high sanitary conditions.
With the growth of home-based therapy, lightweight polysomnography monitoring tools, portable TENS/ultrasound devices, and lightweight EMS compression sleeves empower patients to execute clinical-grade therapy regimens at home while continuously transmitting biological metrics to remote physicians.
Ensuring seamless market entry and zero-friction customs clearance across regulated international healthcare jurisdictions.
Navigating the complex regulatory landscape of international medical device markets requires absolute commitment to compliance documentation, risk management, and rigorous product testing. Ningbo FoysMed Solutions Co., Ltd. maintains a full suite of international quality management certifications and product clearances, providing our OEM clients and commercial partners with technical documentation dossiers formatted for immediate submission to regulatory authorities worldwide.
Our quality engineering team strictly adheres to ISO 13485:2016 (Medical Devices - Quality Management Systems), ensuring total traceability from raw material batch sourcing to finished-goods distribution. Products intended for the European Union comply fully with the stringent requirements of the EU Medical Device Regulation (MDR 2017/745), supported by comprehensive clinical evaluation reports (CER) and ISO 10993 biocompatibility testing. Furthermore, our electronic devices adhere to IEC 60601-1 electrical safety and electromagnetic compatibility (EMC) standards, while our single-use infusion consumables are engineered 100% free of DEHP and hazardous plasticizers.
Discover our specialized laboratory equipment, dental devices, institutional water treatment plants, and patient vital monitoring systems.
Technical and commercial clarity for institutional buyers, procurement directors, and healthcare distributors.
FoysMed Solutions
